What is the appropriate management for a patient presenting with hypotension and acute hearing loss?

Immediate Management: Stabilize Blood Pressure First, Then Urgently Evaluate Hearing Loss

For a patient presenting with hypotension and acute hearing loss, immediately stabilize the blood pressure with IV fluids and vasopressors if needed (phenylephrine 1-10 mcg/kg/min or dopamine 5-15 mcg/kg/min), then urgently distinguish between sensorineural and conductive hearing loss to guide definitive management 1, 2.

Initial Stabilization and Assessment

The combination of hypotension and hearing loss requires immediate attention to both systems, as hypotension itself can compromise inner ear perfusion and worsen auditory outcomes.

Blood Pressure Management

• Ensure adequate hydration as first-line intervention
• For persistent hypotension despite fluids:
  • IV phenylephrine (1-10 mcg/kg/min) or dopamine (5-15 mcg/kg/min) 1
  • Oral ephedrine (25-50 mg, 3-4 times daily) may be useful for persistent but less severe hypotension 1
• Monitor continuously with ECG and blood pressure monitoring 1

Urgent Hearing Assessment

Clinicians must distinguish sensorineural from conductive hearing loss at initial presentation 2. This is a strong recommendation from the 2019 AAO-HNS guideline and is critical for appropriate management.

• Perform tuning fork tests (Weber and Rinne) immediately at bedside
• Obtain pure tone audiometry as soon as feasible 3
• Document timing: sudden sensorineural hearing loss is defined as >30 dB loss over ≤72 hours across three consecutive frequencies 4

Consider Vascular Etiologies

The combination of hypotension and hearing loss should raise suspicion for specific vascular causes:

Subclavian Steal Syndrome

This is a critical diagnosis not to miss. A recent 2026 case report demonstrates that subclavian steal can present initially with sudden sensorineural hearing loss and vertigo 5. Look for:

• Upper extremity ischemic symptoms (arm claudication, weakness)
• Blood pressure differential between arms (>15 mmHg)
• Vertebrobasilar insufficiency symptoms (vertigo, visual changes)
• If suspected: obtain Doppler ultrasonography showing retrograde vertebral artery flow, followed by CT angiography 5
• Early vascular imaging and prompt revascularization are critical to avoid permanent cochlear injury 5

Spontaneous Intracranial Hypotension

Consider this if the patient has:

• Orthostatic headache (worse when upright)
• Hearing loss that worsens with standing or effort 6, 7
• Associated neck/back pain, nausea, vertigo 6
• Predominantly low-frequency hearing loss bilaterally 6, 7
• Diagnosis: MRI showing dural thickening, venous engorgement in internal acoustic canals; lumbar puncture with low/absent CSF pressure 8, 6, 7
• Treatment: autologous epidural blood patch is curative 8, 6

Management of Idiopathic Sudden Sensorineural Hearing Loss

If no specific vascular or systemic cause is identified after initial workup:

Immediate Medical Treatment

Begin high-dose oral corticosteroids immediately - this is time-sensitive:

• Prednisone 60-80 mg daily for 10 days 9
• Maximum hearing improvement occurs within 2 weeks of onset 9
• Do not delay treatment waiting for MRI results

Imaging

• MRI with gadolinium dedicated to internal auditory canals is indicated to rule out cerebellopontine angle tumors and other structural causes 9, 3
• If MRI contraindicated: obtain CT or auditory brainstem response testing 3

Salvage Therapy

If no improvement with oral steroids or if systemic steroids are contraindicated:

• Intratympanic steroid injection as salvage or primary therapy 3, 10
• Hyperbaric oxygen therapy (HBOT): Moderate evidence supports HBOT combined with steroids when applied within 30 days of onset (RR 1.6 for improvement, 95% CI 1.3-2.0; mean improvement 15.6 dB) 4

Critical Pitfalls to Avoid

1. Do not assume hearing loss is secondary to hypotension alone - it may indicate a primary vascular process requiring specific intervention (subclavian steal, vertebrobasilar insufficiency)
2. Do not delay corticosteroid treatment - spontaneous improvement occurs in two-thirds of patients, but early treatment may improve outcomes 9
3. Do not forget to check for positional variation in hearing loss and symptoms, which suggests intracranial hypotension 6, 7
4. Do not routinely use antiviral therapy - insufficient evidence 3

Patient Education and Follow-up

Educate patients about natural history, treatment benefits/risks, and evidence limitations - this is a strong recommendation 2. Specifically discuss:

• Two-thirds spontaneous improvement rate
• Time-sensitive nature of treatment
• Possibility of permanent hearing loss despite treatment

For residual hearing loss or tinnitus, counsel about audiological rehabilitation including hearing aids, assistive devices, and tinnitus management strategies 2.

Prognostic Factors

Better outcomes with:

• Early presentation and treatment initiation
• Mild hearing loss (<90 dB)
• Upward-sloping audiogram
• Recovery beginning within 2 weeks 9

Worse prognosis with:

• Severe hearing loss (>90 dB)
• Flat or downsloping audiogram
• Advanced age
• Presence of vertigo 9